Related Articles
IL‑32 promotes breast cancer cell growth and invasiveness
B7-H3 overexpression in pancreatic cancer promotes tumor progression
Establishment of highly invasive pancreatic cancer cell lines and the expression of IL‑32
Interleukin-17A promotes esophageal adenocarcinoma cell invasiveness through ROS-dependent, NF-κB-mediated MMP-2/9 activation
Reduced kinase D‑interacting substrate of 220 kDa (Kidins220) in pancreatic cancer promotes EGFR/ERK signalling and disease progression